Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.80 -0.06 (-0.62%)
As of: Oct 22, 2026 · 11:12 AM EDT

Aspire Biopharma Holdings, Inc. (ASBP) Research & Development (2024 - 2026)

Updated

Aspire Biopharma Holdings' Research & Development came in at $233,482 for Q2 2026, down 33.8% from $352,887 a year earlier and down 21.3% from the prior quarter.

Analysis

Aspire Biopharma Holdings, Inc. (ASBP) Research & Development (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Aspire Biopharma Holdings reported Research & Development of $838,139, up 13.4% year-over-year; for FY2025, it was $923,914, up 540.0% from FY2024.

  • Going back by year, Research & Development was $144,356 in FY2024 (+100.4%) and $72,050 in FY2023.
  • The five-year range for quarterly Research & Development is $7,000 (Q3 2024) to $352,887 (Q2 2025).
  • Business Quant data shows ASBP's Research & Development at $296,723 (Q1 2026), $100,035 (Q4 2025) and $207,899 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 233,482.00
Mar 31, 2026 296,723.00
Dec 31, 2025 100,035.00
Sep 30, 2025 207,899.00
Jun 30, 2025 352,887.00
Mar 31, 2025 263,093.00
Dec 31, 2024 116,356.00
Sep 30, 2024 7,000.00
Jun 30, 2024 10,500.00
Mar 31, 2024 10,500.00
API Access

Aspire Biopharma Holdings, Inc. Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=ASBP&period=max&api_key=YOUR_API_KEY